P2X purinergic receptor
P2X purinergic receptor is a famliy of ATP-gated cation channels. It is widely distributed in the body and paly an important role in regulation of synaptic transmission, vascular endothelium and nociception etc.
Products for P2X purinergic receptor
- Cat.No. Product Name Information
-
BCC1251
IvermectinPositive allosteric modulator for P2X4 receptor
-
BCC1316
A 438079P2X7 receptor antagonist,competitive and selective
-
BCC1317
A 438079 hydrochlorideCompetitive P2X7 antagonist
-
BCC1320
A-317491P2X3 and P2X2/3 receptor antagonist
-
BCC1681
KN-92 hydrochlorideInactive derivative of KN-93,control compound
-
BCC1682
KN-92 phosphateK+ channel (Kv) blocker. Inactive analog of KN 93
-
BCC1683
KN-93CaM kinase II inhibitor; also K+ channel blocker (KV)
-
BCC3602
KN-62Non-competitive P2X7 antagonist
-
BCC6005
AZ 10606120 dihydrochloridePotent P2X7 receptor antagonist
-
BCC6155
TC-P 262Selective P2X3, P2X2/3 antagonist
-
BCC6157
Ro 51Potent P2X3, P2X2/3 antagonist
-
BCC6198
A 804598Potent and selective P2X7 antagonist
-
BCC6333
Purotoxin 1Potent P2X3 modulator
-
BCC6725
PPADS tetrasodium saltP2 purinergic antagonist
-
BCC6749
iso-PPADS tetrasodium saltP2X antagonist
-
BCC6918
2-Methylthioadenosine triphosphate tetrasodium saltP2 purinergic agonist
-
BCC6964
NF 279Potent and selective P2X1 antagonist
-
BCC6966
MRS 2219Potentiates P2X1-mediated responses
-
BCC6985
NF 023Selective, competitive P2X1 antagonist
-
BCC7015
PPNDSPotent, selective P2X1 antagonist
-
BCC7043
NF 449Highly selective P2X1 antagonist
-
BCC7079
Suramin hexasodium saltNon-selective P2 antagonist
-
BCC7276
Ro 0437626Selective P2X1 antagonist
-
BCC7367
NF 157Selective P2Y11/P2X1 antagonist
-
BCC7373
TNP-ATP triethylammonium saltPotent, selective P2X antagonist
-
BCC7404
NF 110Potent P2X3 antagonist
-
BCC7548
RO-3Selective P2X3 and P2X2/3 antagonist
-
BCC7643
BzATP triethylammonium saltP2X7 agonist. Also P2X1 and P2Y1 partial agonist
-
BCC7646
AZ 11645373Potent and selective human P2X7 antagonist
-
BCC7717
5-BDBDPotent P2X4 receptor antagonist
-
BCC7855
ATPγS tetralithium salt